Vaxcyte, Inc. (PCVX)
48.78
+0.34
(+0.70%)
USD |
NASDAQ |
May 19, 16:00
48.83
+0.05
(+0.10%)
After-Hours: 20:00
Vaxcyte EPS Diluted (Quarterly) : -2.298 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.182 |
| Cytokinetics, Inc. | -1.671 |
| CareDx, Inc. | 0.0529 |
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| Cogent Biosciences, Inc. | -0.60 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -320.62M |
| Total Expenses (Quarterly) | 320.62M |
| Enterprise Value | 5.423B |
| Earnings Yield | -14.28% |
| Normalized Earnings Yield | -14.28 |